116 related articles for article (PubMed ID: 28493531)
1. Ternary complex of human RORγ ligand-binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment.
Noguchi M; Nomura A; Murase K; Doi S; Yamaguchi K; Hirata K; Shiozaki M; Hirashima S; Kotoku M; Yamaguchi T; Katsuda Y; Steensma R; Li X; Tao H; Tse B; Fenn M; Babine R; Bradley E; Crowe P; Thacher S; Adachi T; Kamada M
Genes Cells; 2017 Jun; 22(6):535-551. PubMed ID: 28493531
[TBL] [Abstract][Full Text] [Related]
2. Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction.
Noguchi M; Nomura A; Doi S; Yamaguchi K; Hirata K; Shiozaki M; Maeda K; Hirashima S; Kotoku M; Yamaguchi T; Katsuda Y; Crowe P; Tao H; Thacher S; Adachi T
Sci Rep; 2018 Nov; 8(1):17374. PubMed ID: 30478402
[TBL] [Abstract][Full Text] [Related]
3. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
[TBL] [Abstract][Full Text] [Related]
4. Atomistic simulations shed new light on the activation mechanisms of RORγ and classify it as Type III nuclear hormone receptor regarding ligand-binding paths.
Saen-Oon S; Lozoya E; Segarra V; Guallar V; Soliva R
Sci Rep; 2019 Nov; 9(1):17249. PubMed ID: 31754232
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins.
Navaratnarajah P; Steele BL; Redinbo MR; Thompson NL
Biochemistry; 2012 Jan; 51(1):19-31. PubMed ID: 22185585
[TBL] [Abstract][Full Text] [Related]
6. Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma.
Kurebayashi S; Nakajima T; Kim SC; Chang CY; McDonnell DP; Renaud JP; Jetten AM
Biochem Biophys Res Commun; 2004 Mar; 315(4):919-27. PubMed ID: 14985100
[TBL] [Abstract][Full Text] [Related]
7. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
[TBL] [Abstract][Full Text] [Related]
8. Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Marcotte DJ; Liu Y; Little K; Jones JH; Powell NA; Wildes CP; Silvian LF; Chodaparambil JV
BMC Struct Biol; 2016 Jun; 16(1):7. PubMed ID: 27246200
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma.
Jin L; Martynowski D; Zheng S; Wada T; Xie W; Li Y
Mol Endocrinol; 2010 May; 24(5):923-9. PubMed ID: 20203100
[TBL] [Abstract][Full Text] [Related]
11. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.
Hua G; Paulen L; Chambon P
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E626-34. PubMed ID: 26712002
[TBL] [Abstract][Full Text] [Related]
12. The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Song Y; Xue X; Wu X; Wang R; Xing Y; Yan W; Zhou Y; Qian CN; Zhang Y; Xu Y
Eur J Med Chem; 2016 Jun; 116():13-26. PubMed ID: 27043267
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation.
Sun N; Yuan C; Ma X; Wang Y; Gu X; Fu W
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513894
[TBL] [Abstract][Full Text] [Related]
15. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).
Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP
Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758
[TBL] [Abstract][Full Text] [Related]
16. Biochanin A enhances RORγ activity through STAT3-mediated recruitment of NCOA1.
Takahashi M; Muromoto R; Kojima H; Takeuchi S; Kitai Y; Kashiwakura JI; Matsuda T
Biochem Biophys Res Commun; 2017 Aug; 489(4):503-508. PubMed ID: 28579428
[TBL] [Abstract][Full Text] [Related]
17. Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement.
Strutzenberg TS; Zhu Y; Novick SJ; Garcia-Ordonez RD; Doebelin C; He Y; Chang MR; Kamenecka TM; Edwards DP; Griffin PR
J Mol Biol; 2021 Nov; 433(22):167258. PubMed ID: 34547329
[TBL] [Abstract][Full Text] [Related]
18. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids.
Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304
[TBL] [Abstract][Full Text] [Related]
19. NMR assignments of SPOC domain of the human transcriptional corepressor SHARP in complex with a C-terminal SMRT peptide.
Mikami S; Kanaba T; Ito Y; Mishima M
Biomol NMR Assign; 2013 Oct; 7(2):267-70. PubMed ID: 22987228
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
